Venture capital fund · 8 deals
Adelaide, SA
Every published round South Australian Venture Capital Fund took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
Companies South Australian Venture Capital Fund has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Myriota | 10 Apr 2020, Series B | 1 | 0 | |
| Lumary | 30 Mar 2021 | 1 | 0 | |
| Fleet Space Technologies | 17 Nov 2021, Series B | 1 | 0 | |
| Fivecast | 2 Jul 2019 | 2 | 0 | |
| FerronovaPrecision cancer treatment technology | 17 Dec 2025, Series A | 1 | 1 | |
| Ferronova | 17 Dec 2025, Series A | 1 | 1 | |
| BiomeBank | 9 Dec 2022 | 1 | 0 |
Companies South Australian Venture Capital Fund's own portfolio page lists that no published round yet places it in. The page is the source; the round is being looked for.
| Company | Site |
|---|---|
| Fleet | - |
| Kid Sense | - |
| Kindship | - |
| Pearler.AI | - |
| Seonix Bio | - |
| Val.AI | - |
Fund closes reported for South Australian Venture Capital Fund, as distinct from the investments it has made.
Companies South Australian Venture Capital Fund has backed that another company then bought. An exit for the holding, not a deal South Australian Venture Capital Fund did.
| Name | Role | Sources |
|---|---|---|
| David Rohrsheim | VENTURE PARTNER | Australian FinTech, SmartCompany, South Australian Venture Capital Fund team page |
Stories naming South Australian Venture Capital Fund. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Roundup of seven trans-Tasman raises worth $93.1m this week, headlined by IND Technology's $50m round, with LawVu also acquiring ClauseBase.
Adelaide medtech Ferronova has banked another $6 million from returning backers to advance its surgical tracer for cancer, lifting Series A funding to $17.5 million; backer parent UltraGreen.ai floated in Singapore this month.
Also movefm.com.au
Adelaide biotech Ferronova added $6 million to its Series A from prior backers, lifting the round's total to $17.5 million; backer Renew's parent Ultragreen.ai floated in Singapore this month.
Also ferronova.com.au·movefm.com.au·Biotech Dispatch·Startup Daily
Adelaide AI firm Fivecast has raised a $30 million Series A led by Ten Eleven, with Main Sequence and the South Australian Venture Capital Fund joining, to expand into overseas markets and grow headcount.
Adelaide cancer-focused biotech Ferronova has secured fresh backing: an investor round led by Irish strategic partner Renew Pharmaceuticals plus a federal research grant, to speed clinical trials in stomach and brain cancers.
Also SmartCompany·SmartCompany·SmartCompany·Startup Daily·Business News Australia·Startup Daily
Adelaide biotech Ferronova announced an A$11 million package: an A$8 million round led by Ireland's Renew Pharmaceuticals plus an A$3 million government CRC-P grant, with existing shareholders Uniseed and Artesian also participating.
Weekly roundup covering 14 startup raises totalling over $260 million, headlined by Synchron's $110 million round, plus Roller's shareholder liquidity payout, Partly's record New Zealand Series A, and several government grants.
Also GrainCorp Ventures·SmartCompany·Startup Daily·SmartCompany·@AuManufacturing·SmartCompany·Startup Daily·Startup Daily·Techboard·SmartCompany·SmartCompany·SmartCompany·SmartCompany·Startup Daily·SmartCompany·Startup Daily·@AuManufacturing·Startup News (WA)·Startup News (WA)
Biotech firm BiomeBank raised $10.65 million from Ellerston Capital, the South Australian Venture Capital Fund and The Hospital Research Foundation to expand manufacturing and advance its microbiome therapies.
Also SmartCompany·Techboard
Profile of David Rohrsheim, ex-Uber Australia chief, who manages the state government's established $50 million venture capital fund for early-stage companies and explains what he seeks in founders.
Interview with David Rohrsheim on managing South Australia's $50 million venture capital fund and chairing InDaily's 40 Under 40 judging panel, and what he looks for in founders.
SAVCF profiles portfolio company Myriota, recalling its March 2018 Series B investment alongside several co-investors and noting astronaut Pam Melroy's appointment to the satellite IoT firm's board.
The South Australian Venture Capital Fund, idle since Blue Sky's collapse, has appointed Artesian as manager with David Rohrsheim leading locally; past fund investments in Myriota and Fivecast are recalled.
Adelaide nanosatellite company Myriota announced a $28 million Series B led by Hostplus and Main Sequence Ventures, recalled its 2018 Series A, and had recently acquired Canadian satellite firm exactEarth.
Also TechCrunch Venture·Startup Daily·SmartCompany·Startup Daily·Startup Daily·Business News Australia
South Australia's government has named Artesian Venture Partners to manage its $50 million venture capital fund, which has previously invested in three companies; Artesian will open a small office at Lot Fourteen.